Induced Innovation and Social Inequality

References

1. ↵
   1. Acemoglu Daron,
   2. Linn Joshua

   . 2004. “Market Size and Innovation: Theory and Evidence from the Pharmaceutical Market.” Quarterly Journal of Economics 119(3):1049–90.

   OpenUrlCrossRefWeb of Science
2. ↵
   1. Acemoglu Daron,
   2. Cutler David M.,
   3. Finkelstein Amy,
   4. Linn Joshua

   . 2006. “Did Medicare Induce Pharmaceutical Innovation?” American Economic Review 96(2):103–107.

   OpenUrlCrossRefPubMed
3. ↵
   1. Agency for Healthcare Research and Quality

   . 2001. Excellence Centers To Eliminate Ethnic/Racial Disparities (EXCEED): Program Brief. AHRQ Publication No. 01-P021. Rockville, Md.: Agency for Healthcare Research and Quality.
4. ↵
   1. Agency for Healthcare Research and Quality

   . 2008. 2007 National Healthcare Disparities Report. AHRQ Publication No. 08-0041. Rockville, Md.: Agency for Healthcare Research and Quality.
5. ↵
   1. Aghion Philippe,
   2. Howitt Peter

   . 1992. “A Model of Growth through Creative Destruction.” Econometrica 60(2):323–51.

   OpenUrlCrossRefWeb of Science
6. ↵
   1. Anspach Renée R.

   1997. Deciding Who Lives. Berkeley, Calif.: University of California Press.
7. ↵
   1. Baker David J.P.

   1996. The Machine in the Nursery: Incubator Technology and the Origins of Newborn Intensive Care. Baltimore, Md.: The Johns Hopkins University Press.
8. ↵
   1. Berman Susan K,
   2. Tanasijevic Milenko J.,
   3. Alvarez Juan G.,
   4. Ludmir Jack,
   5. Lieberman E.,
   6. Richardson Douglas K.

   1996. “Racial Differences in Predictive Value of the TDx FLM S/A Assay.” American Journal of Obstetrics and Gynecology 175(1):73–77.

   OpenUrlCrossRefPubMedWeb of Science
9. ↵
   1. Bhattacharya Jay,
   2. Packalen Mikko

   . 2008. “Is Medicine an Ivory Tower? Induced Innovation, Technological Opportunity, and For-Profit Vs. Non-Profit Innovation.” NBER Working Paper No. 13862. Cambridge, Mass.: National Bureau of Economic Research.
10. ↵
    1. Blondel Beatrice,
    2. Kaminski Monique

    . 2002. “Trends in the Occurrence, Determinants, and Consequences of Multiple Births.” Seminars in Perinataology 26(4):239–49.

    OpenUrlCrossRef
11. ↵
    1. Broussard Danielle L.,
    2. Sappenfield William M.,
    3. Goodman David A.

    2011. “The Black and White of Infant Back Sleeping and Infant Bed Sharing in Florida, 2004–2005.” Maternal and Child Health Journal, DOI: 10.1007/s10995-011-0768-y.

    OpenUrlCrossRef
12. 1. Centers for Disease Control and Prevention

    . 2005. “Racial/Ethnic Disparities in Infant Mortality—United States, 1995–2002.” Morbidity and Mortality Weekly Report 54(22):553–56.

    OpenUrl
13. ↵
    1. Cutler David M.

    2004. Your Money or Your Life. New York: Oxford University Press.
14. ↵
    1. Cutler David M.,
    2. Meara Ellen

    . 2000. “The Technology of Birth: Is It Worth It?” In Frontiers in Health Policy Research Volume 3, ed. Garber Alan, 33–67. Cambridge, Mass.: MIT Press.
15. 1. Cutler David M.,
    2. Rosen Allison B.,
    3. Vijan Sandeep

    . 2006. “The Value of Medical Spending in the United States, 1960–2000.” New England Journal of Medicine 355(9):920–27.

    OpenUrlCrossRefPubMedWeb of Science
16. 1. George Lisa,
    2. Waldfogel Joel

    . 2003. “Who Affects Whom in Daily Newspaper Markets?” Journal of Political Economy 111(4):765–84.

    OpenUrlCrossRef
17. ↵
    1. Gross Cary,
    2. Anderson Gerard F.,
    3. Powe Neil R.

    1999. “The Relation between Funding by the national institutes of Health and the Burden of Disease.” New England Journal of Medicine 340(24):1881–87.

    OpenUrlCrossRefPubMedWeb of Science
18. ↵
    1. Grossman Gene,
    2. Helpman Elhanan

    . 1991. Innovation and Growth in the Global Economy. Cambridge, Mass.: Harvard University Press.
19. ↵
    1. Howell Elizabeth A.

    2008. “Racial Disparities in Infant Mortality: A Quality of Care Perspective.” Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine 75(1):31–35.

    OpenUrl
20. ↵
    1. Hulsey Thomas C,
    2. Alexander Greg R.,
    3. Robillard Pierre Y.,
    4. Annibale David J.,
    5. Keenan Andrea

    . 1993. “Hyaline Membrane Disease: The Role of Ethnicity and Maternal Risk Characteristics.” American Journal of Obstetrics and Gynecology 168(2):572–76.

    OpenUrlCrossRefPubMedWeb of Science
21. ↵
    1. Jorgenson Dale W.,
    2. Stiroh Kevin J.

    2000. “Raising the Speed Limit: U.S. Economic Growth in the Information Age.” Brookings Papers on Economic Activity 2000(1):125–212.

    OpenUrlCrossRef
22. ↵
    1. Kremer Michael

    . 2002. “Pharmaceuticals and the Developing World.” Journal of Economic Perspectives 16(4):67–90.

    OpenUrlPubMedWeb of Science
23. ↵
    1. Levy Douglas E,
    2. Meara Ellen

    . 2006. “The Effect of the 1998 Master Settlement Agreement on Prenatal Smoking.” Journal of Health Economics 25(2):276–94.

    OpenUrlCrossRefPubMed
24. ↵
    1. Lichtenberg Frank

    . 2001. “The Allocation of Publicly Funded Biomedical Research.” In Medical Care Output and Productivity. ed. Berndt Ernst, Cutler David. Chicago: University of Chicago Press.
25. 1. National Center for Health Statistics

    . 1983–98. Linked Birth Infant Death Data. Hyattsville, Md.: National Center for Health Statistics.
26. ↵
    1. National Institutes of Health

    . 1994. “The Effect of Corticosteroids for Fetal Maturation on Perinatal Outcomes.” NIH Consensus Statement Online [accessed 5/19/10]; 12(2):1–24.

    OpenUrl
27. ↵
    1. Newell Richard,
    2. Jaffee Adam,
    3. Stavins Robert

    . 1999. “The Induced Innovation Hypothesis and Energy-Saving Technological Change.” Quarterly Journal of Economics 114(3):907–40.

    OpenUrlCrossRefWeb of Science
28. ↵
    1. Newhouse Joseph P.

    1992. “Medical Care Costs: How Much Welfare Loss?” Journal of Economic Perspectives 6(3):3–21.

    OpenUrlPubMedWeb of Science
29. ↵
    1. Popp David

    . 2002. “Induced Innovation and Energy Prices.” American Economic Review 92(1):160–80.

    OpenUrl
30. ↵
    1. Richardson Douglas K.,
    2. Torday John S.

    1994. “Racial Differences in Predictive Value of the Lecithin-sphingomyelin Ratio.” American Journal of Obstetrics and Gynecology 170(5 Part 1):1273–78.

    OpenUrlCrossRefPubMedWeb of Science
31. ↵
    1. Romer Paul M.

    1990. “Endogenous Technological Change.” Journal of Political Economy 98(5 Part 2): S71–S102.

    OpenUrlCrossRefWeb of Science
32. ↵
    1. Schmookler Jacob

    . 1966. Invention and Economic Growth. Cambridge, Mass.: Harvard University Press.
33. ↵
    1. Soll Roger

    . 2000. “Synthetic Surfactant for Respiratory Distress Syndrome in Preterm Infants.” Cochrane Database of Systematic Reviews Issue 2: Article No. CD001149.
34. 1. Waldfogel Joel

    . 2008. “The Median Voter and the Median Consumer: Local Private Goods and Population Composition.” Journal of Urban Economics 63(2):567–82.

    OpenUrlCrossRefWeb of Science
35. ↵
    1. Weisbrod Burton

    . 1991. “The Health Care Quadrilemma: An Essay on Technological Change, Insurance, Quality of Care, and Cost Containment.” Journal of Economic Literature 29(2):523–52.

    OpenUrlWeb of Science